Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29580891 | 1.00 | CA12 (0.38) | CA12CA2CA3CA4CA6 | |
| SCHEMBL23482236 | 0.90 | — | — | |
| SCHEMBL19493258 | 0.89 | CA12 (0.31) | CA12CA2CA3CA4CA6 | |
| SCHEMBL19966943 | 0.85 | PIK3CD (0.50) | — | |
| SCHEMBL14155264 | 0.83 | CA12 (0.38) | CA12CA2CA3CA4CA6 | |
| SCHEMBL13586809 | 0.82 | CHRM2 (0.34) | — | |
| SCHEMBL2964347 | 0.80 | — | — | |
| SCHEMBL12710563 | 0.80 | SIGMAR1 (0.36) | — | |
| SCHEMBL13452815 | 0.80 | — | — | |
| SCHEMBL29581375 | 0.79 | CA12 (0.35) | CA12CA2CA3CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028445-A1 | AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20220144996-A1 | AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-05-12 | — | — | US | claimed |
| US-20260028445-A1 | AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | disclosed |
| US-20220144996-A1 | AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028445-A1 | AMINE COMPOSITION USEFUL FOR MAKING STABLE POLYURETHANE FOAM SYSTEMS | RFC2, RFC3, PUF60 | CA12 2584/4885CA2 1772/4885CA3 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.